Literature DB >> 11827456

Physical and transcript map of the hereditary prostate cancer region at xq27.

Dietrich A Stephan1, Gareth R Howell, Tanya M Teslovich, Alison J Coffey, Lorie Smith, Joan E Bailey-Wilson, Lindsay Malechek, Derek Gildea, Jeffrey R Smith, Elizabeth M Gillanders, Johanna Schleutker, Ping Hu, Helen E Steingruber, Pawandeep Dhami, Christiane M Robbins, Izabela Makalowska, John D Carpten, Raman Sood, Steve Mumm, Rolland Reinbold, Tom I Bonner, Agnes Baffoe-Bonnie, Lukas Bubendorf, Mervi Heiskanen, Olli P Kallioneimi, Andreas D Baxevanis, Shirin S Joseph, Ileana Zucchi, Robert D Burk, William Isaacs, Mark T Ross, Jeffrey M Trent.   

Abstract

We have recently mapped a locus for hereditary prostate cancer (termed HPCX) to the long arm of the X chromosome (Xq25-q27) through a genome-wide linkage study. Here we report the construction of an approximately 9-Mb sequence-ready bacterial clone contig map of Xq26.3-q27.3. The contig was constructed by screening BAC/PAC libraries with markers spaced at approximately 85-kb intervals. We identified overlapping clones by end-sequencing framework clones to generate 407 new sequence-tagged sites, followed by PCR verification of overlaps. Contig assembly was based on clone restriction fingerprinting and the landmark information. We identified a minimal overlap contig for genomic sequencing, which has yielded 7.7 Mb of finished sequence and 1.5 Mb of draft sequence. The transcriptional mapping effort localized 57 known and predicted genes by database searching, STS content mapping, and sequencing, followed by sequence annotation. These transcriptional units represent candidate genes for HPCX and multiple other hereditary diseases at Xq26.3-q27.3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11827456     DOI: 10.1006/geno.2001.6681

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  10 in total

Review 1.  FOXP3 as an X-linked tumor suppressor.

Authors:  Lizhong Wang; Runhua Liu; Mark Ribick; Pan Zheng; Yang Liu
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

2.  Exclusion of the 750-kb genetically unstable region at Xq27 as a candidate locus for prostate malignancy in HPCX1-linked families.

Authors:  Natalay Kouprina; Nicholas C O Lee; Adam Pavlicek; Alexander Samoshkin; Jung-Hyun Kim; Hee-Sheung Lee; Sudhir Varma; William C Reinhold; John Otstot; Greg Solomon; Sean Davis; Paul S Meltzer; Johanna Schleutker; Vladimir Larionov
Journal:  Genes Chromosomes Cancer       Date:  2012-06-26       Impact factor: 5.006

3.  Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27.

Authors:  Natalay Kouprina; Adam Pavlicek; Vladimir N Noskov; Greg Solomon; John Otstot; William Isaacs; John D Carpten; Jeffrey M Trent; Joanna Schleutker; J Carl Barrett; Jerzy Jurka; Vladimir Larionov
Journal:  Genome Res       Date:  2005-11       Impact factor: 9.043

4.  A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.

Authors:  Agnes B Baffoe-Bonnie; Jeffrey R Smith; Dietrich A Stephan; Johanna Schleutker; John D Carpten; Tommi Kainu; Elizabeth M Gillanders; Mika Matikainen; Tanya M Teslovich; Teuvo Tammela; Raman Sood; Andrew M Balshem; Sheehan D Scarborough; Jianfeng Xu; William B Isaacs; Jeffrey M Trent; Olli-P Kallioniemi; Joan E Bailey-Wilson
Journal:  Hum Genet       Date:  2005-05-20       Impact factor: 4.132

5.  Androgen receptor molecular biology and potential targets in prostate cancer.

Authors:  Elizabeth M Wilson
Journal:  Ther Adv Urol       Date:  2010-06

Review 6.  Inactivation of X-linked tumor suppressor genes in human cancer.

Authors:  Runhua Liu; Mandy Kain; Lizhong Wang
Journal:  Future Oncol       Date:  2012-04       Impact factor: 3.404

7.  Expression profile of microRNAs in c-Myc induced mouse mammary tumors.

Authors:  Yuan Sun; Jack Wu; Si-hung Wu; Archana Thakur; Aliccia Bollig; Yong Huang; D Joshua Liao
Journal:  Breast Cancer Res Treat       Date:  2008-09-07       Impact factor: 4.872

8.  Expression of SPANX proteins in normal prostatic tissue and in prostate cancer.

Authors:  M Salemi; A E Calogero; G Zaccarello; R Castiglione; A Cosentino; C Campagna; E Vicari; G Rappazzo
Journal:  Eur J Histochem       Date:  2010       Impact factor: 3.188

9.  NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene.

Authors:  Henna Mattila; Martin Schindler; Jarkko Isotalo; Tarja Ikonen; Mauno Vihinen; Hannu Oja; Teuvo L J Tammela; Tiina Wahlfors; Johanna Schleutker
Journal:  BMC Cancer       Date:  2011-08-02       Impact factor: 4.430

10.  Salivary LDOC1 is a gender-difference biomarker of oral squamous cell carcinoma.

Authors:  Chung-Ji Liu; Jen-Hao Chen; Shih-Min Hsia; Chiu-Chu Liao; Hui-Wen Chang; Tzong-Ming Shieh; Yin-Hwa Shih
Journal:  PeerJ       Date:  2019-04-09       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.